Virus-associated DNA polymerase activity has recently been proposed for the detection of human cytomegalovirus (HCMV) in urine, a method that should allow rapid and quantitative determination of the viral load. In this report, the virus-associated DNA polymerase activity recovered from the urine of a group of patients shedding HCMV was measured using a poly(dA) oligo(dT)12-18 synthetic template after polyethylene glycol precipitation of the virions. Detection of virus-associated DNA polymerase activity was compared to the classical methods most widely used to diagnose HCMV shedding in urines, such as virus culture followed by indirect immunofluorescence and pp65 gene-specific polymerase chain reaction. Although less sensitive than the polymerase chain reaction and cross-reactive with other herpesvirus DNA polymerases, the activity measured in the urine samples was correlated with the number of positive nuclei found in shell vials (r = 0.89). The diagnostic threshold of the assay could be placed between 50 and 100 fluorescent nuclei per shell with a diagnostic sensitivity of 56%. Being simple and quantitative, the measurement of virus-associated DNA polymerase activity could be of value in some clinical conditions where it is necessary to assess viral load in urine. This method is proposed as an alternative to more laborious quantitative assays and to support qualitative polymerase chain reaction.

Keywords:
Cytomegalovirus, Cytomegalovirus, human, DNA polymerase, Polymerase chain reaction
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.